STLN Insider Trading Activity and SEC Form 4 Filings
STLN insider trading summary
Over the past 12 months, insiders at Starling Oncology, Inc. (STLN) reported 1 open-market purchase worth $78K by 1 insider and 1 sale worth $1.9M by 1 insider on SEC Form 4. Net insider selling was $1.9M.
Latest STLN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Brad Hively | Director | Sell | $1.9M (298,853 @ $6.51) |
| Aug 14, 2026 | Jorey Chernett | 10% Owner | Buy | $78K (12,000 @ $6.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.